Article info

Download PDFPDF
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies
  1. Correspondence to:
    Dr S Ogino
    Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA; shuji_ogino{at}dfci.harvard.edu
View Full Text

Citation

Ogino S, Cantor M, Kawasaki T, et al
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies

Publication history

  • Accepted December 20, 2005
  • Revised November 23, 2005
  • First published January 11, 2006.
Online issue publication 
June 09, 2006

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.